Latka logo

Mistral AI vs Sail Biomedicines: Revenue, Funding & Team Size Compared

Mistral AI generates $400M in revenue; Sail Biomedicines has 117 employees. The table below compares Mistral AI and Sail Biomedicines on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Mistral AI vs Sail Biomedicines compared on revenue, funding, valuation, customers and team size
CompanyMistral AI logoMistral AIThis companySail Biomedicines logoSail Biomedicines
Revenue$400MNot disclosed
Valuation$23BNot disclosed
Funding raised$5.5BNot disclosed
Team size350117
Growth300%Not disclosed
Founded20232023
HQParis, FranceCambridge, United States

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Mistral AI logo

Mistral AI at a glance

Mistral AI generates $400M in revenue with 350 employees, headquartered in Paris, France.

Revenue
$400M
Valuation
$23B
Funding
$5.5B
Team size
350
Founded
2023

Fast, open-source and secure language models. Facilitated specialisation of models on business use-cases, leveraging private data and usage feedback.

Sail Biomedicines logo

Sail Biomedicines at a glance

Sail Biomedicines has 117 employees, headquartered in Cambridge, United States.

Team size
117
Founded
2023

Sail Biomedicines is pioneering the integrative design and deployment of fully programmable medicines to transform patient care. We power our bioplatform and product candidates by harnessing evolution and AI.

Other Mistral AI alternatives

Mistral AI competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Mistral AI vs Sail Biomedicines: frequently asked questions

How much revenue does Mistral AI make?

Mistral AI generates $400M in annual revenue with a team of 350.

How much funding has Mistral AI raised?

Mistral AI has raised $5.5B in total funding since it was founded in 2023.